Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6)

Hjalmar Flygt; Stina Söderlund; Johan Richter; Susanne Saussele; Perttu Koskenvesa; Leif Stenke; Satu Mustjoki; Andreja Dimitrijevic; Jesper Stentoft; Waleed Majeed; Lydia Roy; Dominik Wolf; Arta Dreimane; Bjørn Tore Gjertsen; Tobias Gedde-Dahl; Erik Ahlstrand; Berit Markevärn; Henrik Hjorth-Hansen; Jeroen Janssen; Ulla Olsson-Strömberg

doi:10.1038/s41375-024-02184-z

Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6)

Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa, Leif Stenke, Satu Mustjoki, Andreja Dimitrijevic, Jesper Stentoft, Waleed Majeed, Lydia Roy, Dominik Wolf, Arta Dreimane, Bjørn Tore Gjertsen, Tobias Gedde-Dahl, Erik Ahlstrand, Berit Markevärn, Henrik Hjorth-Hansen, Jeroen Janssen, Ulla Olsson-Strömberg

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

Correction to: Leukemiahttps://doi.org/10.1038/s41375-024-02145-6

Original language	English
Pages (from-to)	925
Number of pages	1
Journal	Leukemia
Volume	38
Issue number	4
Early online date	2024
DOIs	https://doi.org/10.1038/s41375-024-02184-z
Publication status	Published - Apr 2024

Access to Document

10.1038/s41375-024-02184-z

Cite this

Flygt, H., Söderlund, S., Richter, J., Saussele, S., Koskenvesa, P., Stenke, L., Mustjoki, S., Dimitrijevic, A., Stentoft, J., Majeed, W., Roy, L., Wolf, D., Dreimane, A., Gjertsen, B. T., Gedde-Dahl, T., Ahlstrand, E., Markevärn, B., Hjorth-Hansen, H., Janssen, J., & Olsson-Strömberg, U. (2024). Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6). Leukemia, 38(4), 925. https://doi.org/10.1038/s41375-024-02184-z

@article{8fadee1a95e64eb18e641613aabc9817,

title = "Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6)",

abstract = "Correction to: Leukemiahttps://doi.org/10.1038/s41375-024-02145-6",

author = "Hjalmar Flygt and Stina S{\"o}derlund and Johan Richter and Susanne Saussele and Perttu Koskenvesa and Leif Stenke and Satu Mustjoki and Andreja Dimitrijevic and Jesper Stentoft and Waleed Majeed and Lydia Roy and Dominik Wolf and Arta Dreimane and Gjertsen, {Bj{\o}rn Tore} and Tobias Gedde-Dahl and Erik Ahlstrand and Berit Markev{\"a}rn and Henrik Hjorth-Hansen and Jeroen Janssen and Ulla Olsson-Str{\"o}mberg",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = apr,

doi = "10.1038/s41375-024-02184-z",

language = "English",

volume = "38",

pages = "925",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

Flygt, H, Söderlund, S, Richter, J, Saussele, S, Koskenvesa, P, Stenke, L, Mustjoki, S, Dimitrijevic, A, Stentoft, J, Majeed, W, Roy, L, Wolf, D, Dreimane, A, Gjertsen, BT, Gedde-Dahl, T, Ahlstrand, E, Markevärn, B, Hjorth-Hansen, H, Janssen, J & Olsson-Strömberg, U 2024, 'Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6)', Leukemia, vol. 38, no. 4, pp. 925. https://doi.org/10.1038/s41375-024-02184-z

Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6). / Flygt, Hjalmar; Söderlund, Stina; Richter, Johan et al.
In: Leukemia, Vol. 38, No. 4, 04.2024, p. 925.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Correction to

T2 - Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6)

AU - Flygt, Hjalmar

AU - Söderlund, Stina

AU - Richter, Johan

AU - Saussele, Susanne

AU - Koskenvesa, Perttu

AU - Stenke, Leif

AU - Mustjoki, Satu

AU - Dimitrijevic, Andreja

AU - Stentoft, Jesper

AU - Majeed, Waleed

AU - Roy, Lydia

AU - Wolf, Dominik

AU - Dreimane, Arta

AU - Gjertsen, Bjørn Tore

AU - Gedde-Dahl, Tobias

AU - Ahlstrand, Erik

AU - Markevärn, Berit

AU - Hjorth-Hansen, Henrik

AU - Janssen, Jeroen

AU - Olsson-Strömberg, Ulla

PY - 2024/4

Y1 - 2024/4

N2 - Correction to: Leukemiahttps://doi.org/10.1038/s41375-024-02145-6

AB - Correction to: Leukemiahttps://doi.org/10.1038/s41375-024-02145-6

UR - http://www.scopus.com/inward/record.url?scp=85186173652&partnerID=8YFLogxK

U2 - 10.1038/s41375-024-02184-z

DO - 10.1038/s41375-024-02184-z

M3 - Comment/Letter to the editor

C2 - 38418611

SN - 0887-6924

VL - 38

SP - 925

JO - Leukemia

JF - Leukemia

IS - 4

ER -

Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L et al. Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6). Leukemia. 2024 Apr;38(4):925. Epub 2024. doi: 10.1038/s41375-024-02184-z

Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6)

Abstract

Access to Document

Other files and links

Cite this